Section 1 - Basic Principles
Published online by Cambridge University Press: 03 December 2019
Summary
A summary is not available for this content so a preview has been provided. Please use the Get access link above for information on how to access this content.
- Type
- Chapter
- Information
- Personalized AnaesthesiaTargeting Physiological Systems for Optimal Effect, pp. 1 - 102Publisher: Cambridge University PressPrint publication year: 2020
References
References
Avram, MJ, Krejcie, TC: Using front-end kinetics to optimize target-controlled drug infusions. Anesthesiology. 2003; 99: 1078–86.CrossRefGoogle ScholarPubMed
Krejcie, TC, Avram, MJ: Recirculatory pharmacokinetic modeling: what goes around, comes around. Anesth.Analg. 2012; 115: 223–6.CrossRefGoogle ScholarPubMed
Krejcie, TC, Avram, MJ: What determines anesthetic induction dose? It’s the front-end kinetics, doctor! Anesth.Analg. 1999; 89: 541–4.Google Scholar
Schnider, TW, Minto, CF, Shafer, SL, Gambus, PL, Andresen, C, Goodale, DB, Youngs, EJ: The influence of age on propofol pharmacodynamics. Anesthesiology. 1999; 90: 1502–16.Google Scholar
Schnider, TW, Minto, CF, Gambus, PL, Andresen, C, Goodale, DB, Shafer, SL, Youngs, EJ: The influence of method of administration and covariates on the pharmacokinetics of propofol in adult volunteers. Anesthesiology. 1998; 88: 1170–82.Google Scholar
Minto, CF, Schnider, TW, Shafer, SL: Pharmacokinetics and pharmacodynamics of remifentanil. II. Model application. Anesthesiology. 1997; 86: 24–33.CrossRefGoogle ScholarPubMed
Minto, CF, Schnider, TW, Egan, TD, Youngs, E, Lemmens, HJ, Gambus, PL, Billard, V, Hoke, JF, Moore, KH, Hermann, DJ, Muir, KT, Mandema, JW, Shafer, SL: Influence of age and gender on the pharmacokinetics and pharmacodynamics of remifentanil. I. Model development. Anesthesiology. 1997; 86: 10–23.Google ScholarPubMed
Minto, CF, Schnider, TW: PKPD Tools for EXCEL (with XLMEM). 1st(1.02). 1995. Stanford, CA: Anesthesia Department., Stanford University School of Medicine. www.pkpdtools.comGoogle Scholar
Sheiner, LB, Stanski, DR, Vozeh, S, Miller, RD, Ham, J: Simultaneous modeling of pharmacokinetics and pharmacodynamics: application to d-tubocurarine. Clin.Pharmacol.Ther. 1979; 25: 358–71.Google Scholar
Hull, CJ, Van Beem, HB, McLeod, K, Sibbald, A, Watson, MJ: A pharmacodynamic model for pancuronium. Br.J.Anaesth. 1978; 50: 1113–23.Google Scholar
Hill, AV: The possible effects of the aggregation of the molecules of hemoglobin on its dissociation curves. J.Physiol. 1910; 40: iv–vii.Google Scholar
Gambus, PL, Gregg, KM, Shafer, SL: Validation of the alfentanil canonical univariate parameter as a measure of opioid effect on the electroencephalogram. Anesthesiology. 1995; 83: 747–56.Google Scholar
Sharma, A, Jusko, WJ: Characterization of four basic models of indirect pharmacodynamic responses. J.Pharmacokinet.Biopharm. 1996; 24: 611–35.CrossRefGoogle ScholarPubMed
Minto, CF, Schnider, TW, Gregg, KM, Henthorn, TK, Shafer, SL: Using the time of maximum effect site concentration to combine pharmacokinetics and pharmacodynamics. Anesthesiology. 2003; 99: 324–33.CrossRefGoogle ScholarPubMed
Cortinez, LI, Nazar, C, Munoz, HR: Estimation of the plasma effect-site equilibration rate constant (ke0) of rocuronium by the time of maximum effect: a comparison with non-parametric and parametric approaches. Br.J.Anaesth. 2007; 99: 679–85.CrossRefGoogle ScholarPubMed
Munoz, HR, Leon, PJ, Fuentes, RS, Echevarria, GC, Cortinez, LI: Prospective evaluation of the time to peak effect of propofol to target the effect site in children. Acta Anaesthesiol.Scand. 2009; 53: 883–90.CrossRefGoogle ScholarPubMed
Munoz, HR, Cortinez, LI, Ibacache, ME, Altermatt, FR: Estimation of the plasma effect site equilibration rate constant (ke0) of propofol in children using the time to peak effect: comparison with adults. Anesthesiology. 2004; 101: 1269–74.CrossRefGoogle ScholarPubMed
Shafer, SL, Varvel, JR: Pharmacokinetics, pharmacodynamics, and rational opioid selection. Anesthesiology. 1991; 74: 53–63.Google Scholar
Eger, EI, Shafer, SL: Tutorial: context-sensitive decrement times for inhaled anesthetics. Anesth.Analg. 2005; 101: 688–96.CrossRefGoogle ScholarPubMed
References
Holford, N: Clinical pharmacology = disease progression + drug action. Br.J.Clin.Pharmacol. 2015; 79: 18–27.CrossRefGoogle ScholarPubMed
Verotta, D, Sheiner, LB: A general conceptual model for non-steady state pharmacokinetic/pharmacodynamic data. J.Pharmacokinet.Biopharm. 1995; 23: 1–4.CrossRefGoogle ScholarPubMed
Tozer, TN, Rowland, M: Introduction to Pharmacokinetics and Pharmacodynamics: The Quantitative Basis of Drug Therapy. Philadelphia, PA: Lippincott Williams & Wilkins, 2006.Google Scholar
Holford, NH, Sheiner, LB: Understanding the dose-effect relationship: clinical application of pharmacokinetic-pharmacodynamic models. Clin.Pharmacokinet. 1981; 6: 429–53.Google Scholar
Schnider, TW, Minto, CF, Gambus, PL, Andresen, C, Goodale, DB, Shafer, SL. Youngs, EJ: The influence of method of administration and covariates on the pharmacokinetics of propofol in adult volunteers. Anesthesiology. 1998; 88: 1170–82.Google Scholar
Hannivoort, LN, Eleveld, DJ, Proost, JH, Reyntjens, KM, Absalom, AR, Vereecke, HE, Struys, MM: Development of an optimized pharmacokinetic model of dexmedetomidine using target-controlled infusion in healthy volunteers. Anesthesiology. 2015; 123: 357–67.CrossRefGoogle ScholarPubMed
Fernández-Candil, J, Gambús, PL, Trocóniz, IF, Valero, R, Carrero, E, Bueno, L, Fábregas, N: Pharmacokinetic-pharmacodynamic modeling of the influence of chronic phenytoin therapy on the rocuronium bromide response in patients undergoing brain surgery. Eur.J.Clin.Pharmacol. 2008; 64: 795–806.CrossRefGoogle Scholar
Trocóniz, IF, Armenteros, S, Planelles, MV, Benítez, J, Calvo, R, Domínguez, R: Pharmacokinetic-pharmacodynamic modelling of the antipyretic effect of two oral formulations of ibuprofen. Clin.Pharmacokinet. 2000; 38: 505–18.Google ScholarPubMed
Anderson, BJ, Holford, NH: Understanding dosing: children are small adults, neonates are immature children. Arch.Dis.Child 2013; 98: 737–44.Google Scholar
Holford, N, Heo, YA, Anderson, B: A pharmacokinetic standard for babies and adults. J.Pharm.Sci. 2013; 102: 2941–52.Google Scholar
Allegaert, K, Holford, N, Anderson, BJ, Holford, S, Stuber, F, Rochette, A, Trocóniz, IF, Beier, H, de Hoon, JN, Pedersen, RS, Stamer, U: Tramadol and o-desmethyl tramadol clearance maturation and disposition in humans: a pooled pharmacokinetic study. Clin.Pharmacokinet. 2015; 54: 167–78.Google Scholar
Anderson, BJ, Larsson, P: A maturation model for midazolam clearance. Paediatr.Anaesth. 2011; 21: 302–8.Google Scholar
Björkman, S, Wada, DR, Stanski, DR, Ebling, WF: Comparative physiological pharmacokinetics of fentanyl and alfentanil in rats and humans based on parametric single-tissue models. J.Pharmacokinet.Biopharm. 1994; 22: 381–410.CrossRefGoogle ScholarPubMed
Masui, K, Upton, RN, Doufas, AG, Coetzee, JF, Kazama, T, Mortier, EP, Struys, MM: The performance of compartmental and physiologically based recirculatory pharmacokinetic models for propofol: a comparison using bolus, continuous, and target-controlled infusion data. Anesth.Analg. 2010; 111: 368–79.Google Scholar
Levitt, DG, Schnider, TW: Human physiologically based pharmacokinetic model for propofol. BMC Anesthesiol. 2005; 5: 4.CrossRefGoogle ScholarPubMed
Holford, NH, Sheiner, LB: Kinetics of pharmacologic response. Pharmacol.Ther. 1982; 16: 143–66.Google Scholar
Yassen, A, Olofsen, E, Dahan, A. Danhof, M: Pharmacokinetic-pharmacodynamic modeling of the antinociceptive effect of buprenorphine and fentanyl in rats: role of receptor equilibration kinetics. J.Pharmacol.Exp.Ther 2005; 313: 1136–49.Google Scholar
Yassen, A, Olofsen, E, Romberg, R, Sarton, E, Teppema, L, Danhof, M. Dahan, A: Mechanism-based PK/PD modeling of the respiratory depressant effect of buprenorphine and fentanyl in healthy volunteers. Clin.Pharmacol.Ther. 2007; 81: 50–8.CrossRefGoogle ScholarPubMed
Borrat, X, Trocóniz, IF, Valencia, JF, Rivadulla, S, Sendino, O, Llach, J, Muñoz, J, Castellví-Bel, S, Jospin, M, Jensen, EW, Castells, A, Gambús, PL: Modeling the influence of the A118G polymorphism in the OPRM1 gene and of noxious stimulation on the synergistic relation between propofol and remifentanil: sedation and analgesia in endoscopic procedures. Anesthesiology. 2013; 118: 1395–407.Google Scholar
Jonker, DM, Voskuyl, RA, Danhof, M. Pharmacodynamic analysis of the anticonvulsant effects of tiagabine and lamotrigine in combination in the rat. Epilepsia. 2004; 45: 424–35.CrossRefGoogle ScholarPubMed
Minto, CF, Schnider, TW, Short, TG, Gregg, KM, Gentilini, A, Shafer, SL: Response surface model for anesthetic drug interactions. Anesthesiology. 2000; 92: 1603–16.CrossRefGoogle ScholarPubMed
Verotta, D, Kitts, J, Rodriguez, R, Coldwell, J, Miller, RD, Sheiner, LB: Reversal of neuromuscular blockade in humans by neostigmine and edrophonium: a mathematical model. J.Pharmacokinet.Biopharm. 1991; 19: 713–29.CrossRefGoogle ScholarPubMed
Wicha, SG, Chen, C, Clewe, O, Simonsson, USH. A general pharmacodynamic interaction model identifies perpetrators and victims in drug interactions. Nat.Commun. 2017; 8: 2129.Google Scholar
Segre, G. Kinetics of interaction between drugs and biological systems. Farmaco Sci. 1968; 23: 907–18.Google Scholar
Sheiner, LB, Stanski, DR, Vozeh, S, Miller, RD, Ham, J: Simultaneous modeling of pharmacokinetics and pharmacodynamics: application to d-tubocurarine. Clin.Pharmacol.Ther. 1979; 25: 358–71.CrossRefGoogle ScholarPubMed
Struys, MM, Coppens, MJ, De Neve, N, Mortier, EP, Doufas, AG, Van Bocxlaer, JF, Shafer, SL: Influence of administration rate on propofol plasma-effect site equilibration. Anesthesiology. 2007; 107: 386–96.Google Scholar
Wright, PM, McCarthy, G, Szenohradszky, J, Sharma, ML, Caldwell, JE: Influence of chronic phenytoin administration on the pharmacokinetics and pharmacodynamics of vecuronium. Anesthesiology. 2004; 100: 626–33.Google Scholar
Olofsen, E, Burm, AG, Simon, MJ, Veering, BT, van Kleef, JW, Dahan, A: Population pharmacokinetic-pharmacodynamic modeling of epidural anesthesia. Anesthesiology. 2008; 109: 664–74.Google Scholar
Dayneka, NL, Garg, V. Jusko, WJ: Comparison of four basic models of indirect pharmacodynamic responses. J.Pharmacokinet.Biopharm. 1993; 21: 457–78.Google Scholar
Hannam, JA, Borrat, X, Trocóniz, IF, Valencia, JF, Jensen, EW, Pedroso, A, Muñoz, J, Castellví-Bel, S, Castells, A, Gambús, PL: Modeling respiratory depression induced by remifentanil and propofol during sedation and analgesia using a continuous non-invasive measurement of pCO2. J.Pharmacol.Exp.Ther. 2016; 356: 563–73.CrossRefGoogle Scholar
Trocóniz, IF, Wolters, JM, Tillmann, C, Schaefer, HG, Roth, W: Modelling the anti-migraine effects of BIBN 4096 BS: a new calcitonin gene-related peptide receptor antagonist. Clin.Pharmacokinet. 2006; 45: 715–28.Google Scholar
Mandema, JW, Stanski, DR: Population pharmacodynamic model for ketorolac analgesia. Clin.Pharmacol.Ther. 1996; 60: 619–35.CrossRefGoogle ScholarPubMed
Fábregas, N, Rapado, J, Gambús, PL, Valero, R, Carrero, E, Salvador, L, Nalda-Felipe, MA, Trocóniz, IF: Modeling of the sedative and airway obstruction effects of propofol in patients with Parkinson’s disease undergoing stereotactic surgery. Anesthesiology. 2002; 97: 1378–86.Google Scholar
Juul, RV, Rasmussen, S, Kreilgaard, M, Christrup, LL, Simonsson, US, Lund, TM: Repeated time-to-event analysis of consecutive analgesic events in postoperative pain. Anesthesiology. 2015; 123: 1411–19.Google Scholar
Bonate, PL: Pharmacokinetic-pharmacodynamic Modeling and Simulation. New York: Springer, 2005.Google Scholar
Beal, S, Sheiner, LB, Boeckmann, A, Bauer, RJ: NONMEM User’s Guides (1989–2015). Ellicott City: Icon Development Solutions, 2015.Google Scholar
Monolix version 192018R1. Antony, France: Lixoft SAS, 2018. http://lixoft.com/products/monolix/ [last accessed 6 June 2019].Google Scholar
Petersson, KJ, Hanze, E, Savic, RM, Karlsson, MO: Semiparametric distributions with estimated shape parameters. Pharm.Res. 2009 Sep; 26(9): 2174–85.CrossRefGoogle ScholarPubMed
Carlsson, KC, Savić, RM, Hooker, AC, Karlsson, MO: Modeling subpopulations with the $MIXTURE subroutine in NONMEM: finding the individual probability of belonging to a subpopulation for the use in model analysis and improved decision making. AAPS J. 2009 Mar; 11(1): 148–54.CrossRefGoogle ScholarPubMed
Ludden, TM, Beal, SL, Sheiner, LB: Comparison of the Akaike information criterion, the Schwarz criterion and the F test as guides to model selection. J.Pharmacokinet.Biopharm. 1994; 22: 431–45.Google Scholar
Jonsson, E, Karlsson, MO: Automated covariate model building within NONMEM. Pharm.Res. 1998; 15: 1463–8.CrossRefGoogle ScholarPubMed
Lindbom, L, Pihlgren, P, Jonsson, EN: PsN toolkit: a collection of computer intensive statistical methods for nonlinear mixed effect modelling using NONMEM. Comput. Methods. Programs. Biomed. 2005; 79: 241–57.Google Scholar
Minto, CF, Schnider, TW, Egan, TD, Youngs, E, Lemmens, HJ, Gambus, PL, Billard, V, Hoke, JF, Moore, KH, Hermann, DJ, Muir, KT, Mandema, JW, Shafer, SL: Influence of age and gender on the pharmacokinetics and pharmacodynamics of remifentanil. I. Model development. Anesthesiology. 1997; 86: 10–23.CrossRefGoogle ScholarPubMed
Schnider, TW, Minto, CF, Shafer, SL, Gambus, PL, Andresen, C, Goodale, DB, Youngs, EJ: The influence of age on propofol pharmacodynamics. Anesthesiology. 1999; 90: 1502–16.Google Scholar
Cortínez, LI, Trocóniz, IF, Fuentes, R, Gambús, P, Hsu, YW, Altermatt, F, Muñoz, HR: The influence of age on the dynamic relationship between end-tidal sevoflurane concentrations and bispectral index. Anesth.Analg. 2008; 107: 1566–72.CrossRefGoogle ScholarPubMed
Sarton, E, Olofsen, E, Romberg, R, den Hartigh, J, Kest, B, Nieuwenhuijs, D, Burm, A, Teppema, L, Dahan, A: Sex differences in morphine analgesia: an experimental study in healthy volunteers. Anesthesiology. 2000; 93: 1245–54.Google Scholar
Romberg, RR, Olofsen, E, Bijl, H, Taschner, PE, Teppema, LJ, Sarton, EY, van Kleef, JW, Dahan, A: Polymorphism of mu-opioid receptor gene (OPRM1:c.118A>G) does not protect against opioid-induced respiratory depression despite reduced analgesic response. Anesthesiology. 2005; 102: 522–30.CrossRefGoogle Scholar
Bergstrand, M, Hooker, AC, Wallin, JE, Karlsson, MO: Prediction-corrected visual predictive checks for diagnosing nonlinear mixed-effects models. AAPS J. 2011; 13 (2): 143–51.Google Scholar
References
Lichtenbelt, BJ, Olofsen, E, Dahan, A, van Kleef, JW, Struys, MMRF, Vuyk, J: Propofol reduces the distribution and clearance of midazolam. Anesth.Analg. 2010; 110(6): 1597–606.Google Scholar
Vuyk, J, Lichtenbelt, BJ, Olofsen, E, van Kleef, JW, Dahan, A: Mixed-effects modeling of the influence of midazolam on propofol pharmacokinetics. Anesth.Analg. 2009; 108(5): 1522–30.Google Scholar
Mertens, MJ, Vuyk, J, Olofsen, E, Bovill, JG, Burm, AG: Propofol alters the pharmacokinetics of alfentanil in healthy male volunteers. Anesthesiology. 2001; 94(6): 949–57.Google Scholar
Manyam, SC, Gupta, DK, Johnson, KB, White, JL, Pace, NL, Westenskow, DR, et al: Opioid-volatile anesthetic synergy: a response surface model with remifentanil and sevoflurane as prototypes. Anesthesiology. 2006; 105(2): 267–78.Google Scholar
Loewe, S: The problem of synergism and antagonism of combined drugs. Arzneimittelforschung. 1953; 3(6): 285–90.Google Scholar
Short, TG, Chui, PT: Propofol and midazolam act synergistically in combination. Br.J.Anaesth. 1991; 67(5): 539–45.Google Scholar
Kissin, I, Vinik, HR, Bradley, EL, Jr.: Midazolam potentiates thiopental sodium anesthetic induction in patients. J.Clin.Anesth. 1991; 3(5): 367–70.Google Scholar
Hill, A: The possible effects of the aggregation of the molecules of haemoglobin on its dissociation curves. J.Physiol. 1910; 40(Suppl): i–vii.Google Scholar
Greco, WR, Park, HS, Rustum, YM: Application of a new approach for the quantitation of drug synergism to the combination of cis-diamminedichloroplatinum and 1-beta-D-arabinofuranosylcytosine. Cancer Res. 1990; 50(17): 5318–27.Google Scholar
Minto, CF, Schnider, TW, Short, TG, Gregg, KM, Gentilini, A, Shafer, SL: Response surface model for anesthetic drug interactions. Anesthesiology. 2000; 92(6): 1603–16.Google Scholar
Bouillon, TW, Bruhn, J, Radulescu, L, Andresen, C, Shafer, TJ, Cohane, C, et al: Pharmacodynamic interaction between propofol and remifentanil regarding hypnosis, tolerance of laryngoscopy, bispectral index, and electroencephalographic approximate entropy. Anesthesiology. 2004; 100(6): 1353–72.CrossRefGoogle ScholarPubMed
Mertens, MJ, Olofsen, E, Engbers, FH, Burm, AG, Bovill, JG, Vuyk, J: Propofol reduces perioperative remifentanil requirements in a synergistic manner: response surface modeling of perioperative remifentanil-propofol interactions. Anesthesiology. 2003; 99(2): 347–59.CrossRefGoogle Scholar
Heyse, B, Proost, JH, Schumacher, PM, Bouillon, TW, Vereecke, HE, Eleveld, DJ, et al: Sevoflurane remifentanil interaction: comparison of different response surface models. Anesthesiology. 2012; 116(2): 311–23.Google Scholar
Short, TG, Ho, TY, Minto, CF, Schnider, TW, Shafer, SL: Efficient trial design for eliciting a pharmacokinetic-pharmacodynamic model-based response surface describing the interaction between two intravenous anesthetic drugs. Anesthesiology. 2002; 96(2): 400–8.Google Scholar
LaPierre, CD, Johnson, KB, Randall, BR, White, JL, Egan, TD, Yang, L, et al: An exploration of remifentanil-propofol combinations that lead to a loss of response to esophageal instrumentation, a loss of responsiveness, and/or onset of intolerable ventilatory depression. Anesth.Analg. 2011; 113(3): 441–3.Google Scholar
Vuyk, J, Lim, T, Engbers, FH, Burm, AG, Vletter, AA, Bovill, JG: The pharmacodynamic interaction of propofol and alfentanil during lower abdominal surgery in women. Anesthesiology. 1995; 83(1): 8–22.Google Scholar
McClune, S, McKay, AC, Wright, PM, Patterson, CC, Clarke, RS: Synergistic interaction between midazolam and propofol. Br.J.Anaesth. 1992; 69(3): 240–5.Google Scholar
Short, TG, Plummer, JL, Chui, PT: Hypnotic and anaesthetic interactions between midazolam, propofol and alfentanil. Br.J.Anaesth. 1992; 69(2): 162–7.Google Scholar
Short, TG, Galletly, DC, Plummer, JL: Hypnotic and anaesthetic action of thiopentone and midazolam alone and in combination. Br.J.Anaesth. 1991; 66(1): 13–19.CrossRefGoogle ScholarPubMed
McAdam, LC, MacDonald, JF, Orser, BA: Isobolographic analysis of the interactions between midazolam and propofol at GABA(A) receptors in embryonic mouse neurons. Anesthesiology. 1998; 89(6): 1444–54.Google Scholar
Ben-Shlomo, I, Abd-el-Khalim, H, Ezry, J, Zohar, S, Tverskoy, M: Midazolam acts synergistically with fentanyl for induction of anaesthesia. Br.J.Anaesth. 1990; 64(1): 45–7.Google Scholar
Kern, SE, Xie, G, White, JL, Egan, TD: A response surface analysis of propofol-remifentanil pharmacodynamic interaction in volunteers. Anesthesiology. 2004; 100(6): 1373–81.Google Scholar
Syroid, ND, Johnson, KB, Pace, NL, Westenskow, DR, Tyler, D, Bruhschwein, F, et al: Response surface model predictions of emergence and response to pain in the recovery room: an evaluation of patients emerging from an isoflurane and fentanyl anesthetic. Anesth.Analg. 2010; 111(2): 380–6.CrossRefGoogle ScholarPubMed
Hannivoort, LN, Vereecke, HEM, Proost, JH, Heyse, BEK, Eleveld, DJ, Bouillon, TW, et al: Probability to tolerate laryngoscopy and noxious stimulation response index as general indicators of the anaesthetic potency of sevoflurane, propofol, and remifentanil. Br.J.Anaesth. 2016; 116(5): 624–31.Google Scholar
Katoh, T, Suguro, Y, Kimura, T, Ikeda, K: Cerebral awakening concentration of sevoflurane and isoflurane predicted during slow and fast alveolar washout. Anesth.Analg. 1993; 77(5): 1012–17.Google Scholar
Katoh, T, Kobayashi, S, Suzuki, A, Iwamoto, T, Bito, H, Ikeda, K: The effect of fentanyl on sevoflurane requirements for somatic and sympathetic responses to surgical incision. Anesthesiology. 1999; 90(2): 398–405.Google Scholar
Katoh, T, Ikeda, K: The effects of fentanyl on sevoflurane requirements for loss of consciousness and skin incision. Anesthesiology. 1998; 88(1): 18–24.Google Scholar
Murray, DJ, Mehta, MP, Forbes, RB, Dull, DL. Additive contribution of nitrous oxide to halothane MAC in infants and children. Anesth.Analg. 1990; 71(2): 120–4.Google Scholar
Stevens, MD, Wendell, C, Dolan, MD, William, M, Gibbons, MD, Robert, T, White, MSA, Eger, MD, Edmond, I, Miller, MD, Ronald, D, et al: Minimum alveolar concentrations (MAC) of isoflurane with and without nitrous oxide in patients of various ages. Anesthesiology. 1975; 42(2): 197–200.Google Scholar
Hendrickx, JFA, Eger, EI, Sonner, JM, Shafer, SL: Is synergy the rule? A review of anesthetic interactions producing hypnosis and immobility. Anesth.Analg. 2008; 107(2): 494–506.Google Scholar
Hong, W, Short, TG, Hui, TW: Hypnotic and anesthetic interactions between ketamine and midazolam in female patients. Anesthesiology. 1993; 79(6): 1227–32.Google Scholar
Hui, TW, Short, TG, Hong, W, Suen, T, Gin, T, Plummer, J: Additive interactions between propofol and ketamine when used for anesthesia induction in female patients. Anesthesiology. 1995; 82(3): 641–8.Google Scholar
Coulter, FL, Hannam, JA, Anderson, BJ: Ketofol simulations for dosing in pediatric anesthesia. Paediatr.Anaesth. 2014; 24(8): 806–12.Google Scholar
Katoh, T, Ikeda, K, Bito, H: Does nitrous oxide antagonize sevoflurane-induced hypnosis? Br.J.Anaesth. 1997; 79(4): 465–8.Google Scholar
Short, TG, Hannam, JA, Laurent, S, Campbell, D, Misur, M, Merry, AF, et al: Refining target-controlled infusion: an assessment of pharmacodynamic target-controlled infusion of propofol and remifentanil using a response surface model of their combined effects on bispectral index. Anesth.Analg. 2016; 122(1): 90–7.Google Scholar
Liu, N, Chazot, T, Hamada, S, Landais, A, Boichut, N, Dussaussoy, C, et al: Closed-loop coadministration of propofol and remifentanil guided by bispectral index: a randomized multicenter study. Anesth.Analg. 2011; 112(3): 546–57.Google Scholar
Agarwal, J, Puri, GD, Mathew, PJ: Comparison of closed loop vs. manual administration of propofol using the bispectral index in cardiac surgery. Acta Anaesthesiol.Scand. 2009; 53(3): 390–7.Google Scholar
Puri, GD, Mathew, PJ, Biswas, I, Dutta, A, Sood, J, Gombar, S, et al: A multicenter evaluation of a closed-loop anesthesia delivery system: a randomized controlled trial. Anesth.Analg. 2016; 122(1): 106–14.Google Scholar
Hemmerling, TM, Charabati, S, Zaouter, C, Minardi, C, Mathieu, PA: A randomized controlled trial demonstrates that a novel closed-loop propofol system performs better hypnosis control than manual administration. Can.J.Anaesth. 2010; 57(8): 725–35.Google Scholar
Struys, MM, De Smet, T, Versichelen, LF, Van De Velde, S, Van den Broecke, R, Mortier, EP: Comparison of closed-loop controlled administration of propofol using bispectral index as the controlled variable versus “standard practice” controlled administration. Anesthesiology. 2001; 95(1): 6–17.Google Scholar
References
Holford, NHG: The target concentration approach to clinical drug development. Clin.Pharmacokinet. 1995; 29 (5): 287–91.Google Scholar
Benet, LZ: Holy, A Grail of clinical pharmacology: prediction of drug pharmacokinetics and pharmacodynamics in the individual patient. Clin.Pharmacol.Ther. 2009; 86 (2): 133–4.Google Scholar
Anderson, BJ, Allegaert, K, Van den Anker, JN, Cossey, V, Holford, NH: Vancomycin pharmacokinetics in preterm neonates and the prediction of adult clearance. Br.J.Clin.Pharmacol. 2007; 63 (1): 75–84.Google Scholar
Tod, M, Jullien, V, Pons, G: Facilitation of drug evaluation in children by population methods and modelling. Clin.Pharmacokinet. 2008; 47 (4): 231–43.Google Scholar
Anderson, BJ, Holford, NH: Understanding dosing: children are small adults, neonates are immature children. Arch.Dis.Child. 2013; 98 (9): 737–44.Google Scholar
Lack, JA, Stuart Taylor, ME: Calculation of drug dosage and body surface area of children. Br.J.Anaesth. 1997; 78 (5): 601–5.Google Scholar
Sumpter, AL, Holford, NH: Predicting weight using postmenstrual age – neonates to adults. Paediatr.Anaesth. 2011; 21 (3): 309–15.Google Scholar
Anderson, BJ, Meakin, GH: Scaling for size: some implications for paediatric anaesthesia dosing. Paediatr.Anaesth. 2002; 12 (3): 205–19.Google Scholar
Anderson, BJ, Holford, NH: Mechanistic basis of using body size and maturation to predict clearance in humans. Drug.Metab.Pharmacokinet. 2009; 24 (1): 25–36.Google Scholar
Du Bois, D, Du Bois, EF: Clinical calorimetry: tenth paper. A formula to estimate the approximate surface area if height and weight be known. Arch.Intern.Med. 1916; 17: 863–71.Google Scholar
Janmahasatian, S, Duffull, SB, Ash, S, Ward, LC, Byrne, NM, Green, B: Quantification of lean bodyweight. Clin.Pharmacokinet. 2005; 44 (10): 1051–65.Google Scholar
Rhodin, MM, Anderson, BJ, Peters, AM, Coulthard, MG, Wilkins, B, Cole, M, et al: Human renal function maturation: a quantitative description using weight and postmenstrual age. Pediatr.Nephrol. 2009; 24 (1): 67–76.CrossRefGoogle ScholarPubMed
West, GB, Brown, JH: The origin of allometric scaling laws in biology from genomes to ecosystems: towards a quantitative unifying theory of biological structure and organization. J.Exp.Biol. 2005; 208 (Pt 9): 1575–92.CrossRefGoogle ScholarPubMed
West, GB, Brown, JH, Enquist, BJ: A general model for the origin of allometric scaling laws in biology. Science. 1997; 276 (5309): 122–6.Google Scholar
Anderson, BJ, Holford, NH: Mechanism-based concepts of size and maturity in pharmacokinetics. Annu.Rev.Pharmacol.Toxicol. 2008; 48: 303–32.Google Scholar
Holford, S, Allegaert, K, Anderson, BJ, Kukanich, B, Sousa, AB, Steinman, A, et al: Parent-metabolite pharmacokinetic models for tramadol – tests of assumptions and predictions. J.Pharmacol.Clin.Toxicol. 2014; 2 (1): 1023.Google Scholar
Ross, AK, Davis, PJ, Gd GL, Dear, Ginsberg, B, McGowan, FX, Stiller, RD, et al: Pharmacokinetics of remifentanil in anesthetized pediatric patients undergoing elective surgery or diagnostic procedures. Anesth.Analg. 2001; 93 (6): 1393–401.Google Scholar
Rigby-Jones, AE, Priston, MJ, Sneyd, JR, McCabe, AP, Davis, GI, Tooley, MA, et al: Remifentanil-midazolam sedation for paediatric patients receiving mechanical ventilation after cardiac surgery. Brit.J.Anaesth. 2007; 99 (2): 252–61.Google Scholar
Welzing, L, Ebenfeld, S, Dlugay, V, Wiesen, MH, Roth, B, Mueller, C: Remifentanil degradation in umbilical cord blood of preterm infants. Anesthesiology. 2011; 114 (3): 570–7.CrossRefGoogle ScholarPubMed
Potts, AL, Larsson, P, Eksborg, S, Warman, G, Lonnqvist, P-A, Anderson, BJ: Clonidine disposition in children; a population analysis. Pediatr.Anesth. 2007; 17 (10): 924–33.Google Scholar
Anderson, BJ, van Lingen, RA, Hansen, TG, Lin, YC, Holford, NH: Acetaminophen developmental pharmacokinetics in premature neonates and infants: a pooled population analysis. Anesthesiology. 2002; 96 (6): 1336–45.Google Scholar
Herd, D, Anderson, BJ: Ketamine disposition in children presenting for procedural sedation and analgesia in a children’s emergency department. Paediatr.Anaesth. 2007; 17 (7): 622–9.Google Scholar
Chalkiadis, GA, Anderson, BJ: Age and size are the major covariates for prediction of levobupivacaine clearance in children. Paediatr.Anaesth. 2006; 16 (3): 275–82.Google Scholar
Allegaert, K, van den Anker, JN, de Hoon, JN, van Schaik, RH, Debeer, A, Tibboel, D, et al: Covariates of tramadol disposition in the first months of life. Brit.J.Anaesth. 2008; 100 (4): 525–32.Google Scholar
Allegaert, K, Anderson, BJ, van den Anker, JN, Vanhaesebrouck, S, de Zegher, F: Renal drug clearance in preterm neonates: relation to prenatal growth. Ther.Drug.Monit. 2007; 29 (3): 284–91.Google Scholar
Johnson, TN: The problems in scaling adult drug doses to children. Arch.Dis.Child. 2008; 93 (3): 207–11.CrossRefGoogle ScholarPubMed
Edginton, AN, Schmitt, W, Voith, B, Willmann, S: A mechanistic approach for the scaling of clearance in children. Clin.Pharmacokinet. 2006; 45 (7): 683–704.Google Scholar
Holford, N, Heo, YA, Anderson, B: A pharmacokinetic standard for babies and adults. J.Pharm.Sci. 2013; 102 (9): 2941–52.Google Scholar
Hill, AV: The possible effects of the aggregation of the molecules of haemoglobin on its dissociation curves. J.Physiol. 1910; 14: iv–vii.Google Scholar
Saarenmaa, E, Neuvonen, PJ, Fellman, V. Gestational age and birth weight effects on plasma clearance of fentanyl in newborn infants. J.Pediatr. 2000; 136 (6): 767–70.Google Scholar
Allegaert, K, Palmer, GM, Anderson, BJ: The pharmacokinetics of intravenous paracetamol in neonates: size matters most. Arch.Dis.Child. 2011; 96 (6): 575–80.Google Scholar
Anderson, BJ, Pons, G, Autret-Leca, E, Allegaert, K, Boccard, E: Pediatric intravenous paracetamol (propacetamol) pharmacokinetics: a population analysis. Paediatr.Anaesth. 2005; 15 (4): 282–92.Google Scholar
Pokela, ML, Olkkola, KT, Seppala, T, Koivisto, M: Age-related morphine kinetics in infants. Dev.Pharmacol.Ther. 1993; 20 (1–2): 26–34.Google Scholar
Peters, JW, Anderson, BJ, Simons, SH, Uges, DR, Tibboel, D: Morphine metabolite pharmacokinetics during venoarterial extra corporeal membrane oxygenation in neonates. Clin.Pharmacokinet. 2006; 45 (7): 705–14.Google Scholar
Anand, KJ, Anderson, BJ, Holford, NH, Hall, RW, Young, T, Shephard, B, et al: Morphine pharmacokinetics and pharmacodynamics in preterm and term neonates: secondary results from the NEOPAIN trial. Brit.J.Anaesth. 2008; 101 (5): 680–9.CrossRefGoogle ScholarPubMed
Schwartz, GJ, Work, DF: Measurement and estimation of GFR in children and adolescents. CJASN. 2009; 4 (11): 1832–43.Google Scholar
Paap, CM, Nahata, MC: Prospective evaluation of ten methods for estimating creatinine clearance in children with varying degrees of renal dysfunction. J.Clin.Pharm.Ther. 1995; 20 (2): 67–73.Google Scholar
Cole, M, Price, L, Parry, A, Keir, MJ, Pearson, AD, Boddy, AV, et al: Estimation of glomerular filtration rate in paediatric cancer patients using 51CR-EDTA population pharmacokinetics. Br.J.Cancer. 2004; 90 (1): 60–4.CrossRefGoogle ScholarPubMed
Schwartz, GJ, Haycock, GB, Edelmann, CM, Jr., Spitzer, A: A simple estimate of glomerular filtration rate in children derived from body length and plasma creatinine. Pediatrics. 1976; 58 (2): 259–63.Google Scholar
Schwartz, GJ, Feld, LG, Langford, DJ: A simple estimate of glomerular filtration rate in full-term infants during the first year of life. J.Pediatr. 1984; 104 (6): 849–54.Google Scholar
Brion, LP, Fleischman, AR, McCarton, C, Schwartz, GJ: A simple estimate of glomerular filtration rate in low birth weight infants during the first year of life: noninvasive assessment of body composition and growth. J.Pediatr. 1986; 109 (4): 698–707.Google Scholar
Standing, JF: Understanding and applying pharmacometric modelling and simulation in clinical practice and research. Br.J.Clin.Pharmacol. 2017; 83 (2): 247–54.CrossRefGoogle ScholarPubMed
Eleveld, DJ, Colin, P, Absalom, AR, Struys, M: Pharmacokinetic-pharmacodynamic model for propofol for broad application in anaesthesia and sedation. Br.J.Anaesth. 2018; 120 (5): 942–59.Google Scholar
Eleveld, DJ, Proost, JH, Vereecke, H, Absalom, AR, Olofsen, E, Vuyk, J, et al: An allometric model of remifentanil pharmacokinetics and pharmacodynamics. Anesthesiology. 2017; 126 (6): 1005–18.Google Scholar
Cheymol, G: Effects of obesity on pharmacokinetics implications for drug therapy. Clin.Pharmacokinet. 2000; 39 (3): 215–31.CrossRefGoogle ScholarPubMed
Cortinez, LI, Anderson, BJ, Holford, NH, Puga, V, de la Fuente, N, Auad, H, et al: Dexmedetomidine pharmacokinetics in the obese. Eur.J.Clin. Pharm. 2015; 71(12): 1501–8.Google Scholar
Egan, TD, Huizinga, B, Gupta, SK, Jaarsma, RL, Sperry, RJ, Yee, JB, et al: Remifentanil pharmacokinetics in obese versus lean patients. Anesthesiology. 1998; 89 (3): 562–73.Google Scholar
Coldrey, JC, Upton, RN, Macintyre, PE: Advances in analgesia in the older patient. Best practice and research. Clin.Anaesth. 2011; 25 (3): 367–78.Google Scholar
McLean, AJ, Le Couteur, DG: Aging biology and geriatric clinical pharmacology. Pharmacol. Rev. 2004; 56 (2): 163–84.Google Scholar
Le Couteur, DG, McLean, AJ: The aging liver. Drug clearance and an oxygen diffusion barrier hypothesis. Clin.Pharm. 1998; 34 (5): 359–73.Google Scholar
Minto, CF, Schnider, TW, Egan, TD, Youngs, E, Lemmens, HJ, Gambus, PL, et al: Influence of age and gender on the pharmacokinetics and pharmacodynamics of remifentanil. Anesthesiology. 1997; 86: 10–23.Google Scholar
Schuttler, J, Ihmsen, H: Population pharmacokinetics of propofol: a multicenter study. Anesthesiology. 2000; 92 (3): 727–38.Google Scholar
Eleveld, DJ, Proost, JH, Cortinez, LI, Absalom, AR, Struys, MM: A general purpose pharmacokinetic model for propofol. Anesth.Analg. 2014; 118 (6): 1221–37.Google Scholar
Upton, RN, Ludbrook, GL: A physiological model of induction of anaesthesia with propofol in sheep. 1. Structure and estimation of variables. Br.J.Anaesth. 1997; 79 (4): 497–504.Google Scholar
Cortinez, LI, Troconiz, IF, Fuentes, R, Gambus, P, Hsu, YW, Altermatt, F, et al: The influence of age on the dynamic relationship between end-tidal sevoflurane concentration and bispectral index. Anesth.Anal. 2008; 107: 1566–72.Google Scholar
Minto, CF, Schnider, TW, Egan, TD, Youngs, E, Lemmens, HJ, Gambus, PL, et al: Influence of age and gender on the pharmacokinetics and pharmacodynamics of remifentanil. I. Model development. Anesthesiology. 1997; 86 (1): 10–23.Google Scholar
Vuyk, J, Lichtenbelt, BJ, Olofsen, E, van Kleef, JW, Dahan, A: Mixed-effects modeling of the influence of midazolam on propofol pharmacokinetics. Anesth.Analg. 2009; 108 (5): 1522–30.Google Scholar
Verbeeck, RK: Pharmacokinetics and dosage adjustment in patients with hepatic dysfunction. Eur.J.Clin.Pharm. 2008; 64 (12): 1147–61.Google Scholar
Blaschke, TF: Protein binding and kinetics of drugs in liver diseases. Clin.Pharmacokinet. 1977; 2 (1): 32–44.Google Scholar
Kaivosaari, S, Toivonen, P, Aitio, O, Sipila, J, Koskinen, M, Salonen, JS, et al: Regio- and stereospecific N-glucuronidation of medetomidine: the differences between UDP glucuronosyltransferase (UGT) 1A4 and UGT2B10 account for the complex kinetics of human liver microsomes. Drug.Metab.Dispos. 2008; 36 (8): 1529–37.Google Scholar
Kohli, U, Pandharipande, P, Muszkat, M, Sofowora, GG, Friedman, EA, Scheinin, M, et al: CYP2A6 genetic variation and dexmedetomidine disposition. Eur.J.Clin.Pharm. 2012; 68 (6): 937–42.Google Scholar
Song, JC, Gao, H, Qiu, HB, et al. The pharmacokinetics of dexmedetomidine in patients with obstructive jaundice: A clinical trial. PLoS One 2018; 13: e0207427.Google Scholar
Servin, F, Cockshott, ID, Farinotti, R, Haberer, JP, Winckler, C, Desmonts, JM: Pharmacokinetics of propofol infusions in patients with cirrhosis. Br.J.Anaesth. 1990; 65 (2): 177–83.Google Scholar
Elston, AC, Bayliss, MK, Park, GR: Effect of renal failure on drug metabolism by the liver. Br.J.Anaesth. 1993; 71 (2): 282–90.Google Scholar
Chauvin, M, Sandouk, P, Scherrmann, JM, Farinotti, R, Strumza, P, Duvaldestin, P: Morphine pharmacokinetics in renal failure. Anesthesiology. 1987; 66 (3): 327–31.Google Scholar
Hannam, JA, Anderson, BJ: Contribution of morphine and morphine-6-glucuronide to respiratory depression in a child. Anaesth.Intensive.Care. 2012; 40 (5): 867–70.Google Scholar
Verbeeck, RK, Musuamba, FT: Pharmacokinetics and dosage adjustment in patients with renal dysfunction. Eur.J.Clin.Pharm. 2009; 65 (8): 757–73.Google Scholar
Hannam, JA, Anderson, BJ: Pharmacodynamic interaction models in pediatric anesthesia. Paediatr.Anaesth. 2015; 25: 970–80.Google Scholar
Chan, PL, Holford, NH: Drug treatment effects on disease progression. Annu.Rev.Pharmacol.Toxicol. 2001; 41: 625–59.Google Scholar
Brown, RD, Kearns, GL, Wilson, JT: Integrated pharmacokinetic-pharmacodynamic model for acetaminophen, ibuprofen, and placebo antipyresis in children. J.Pharmacokinet.Biopharm. 1998; 26 (5): 559–79.Google Scholar
Lavy, JA: Post-tonsillectomy pain: the difference between younger and older patients. Int.J.Pediatr.Otorhinolaryngol. 1997; 42 (1): 11–15.Google Scholar
Murthy, P, Laing, MR: Dissection tonsillectomy: pattern of post-operative pain, medication and resumption of normal activity. J.Laryngol.Otol. 1998; 112 (1): 41–4.Google Scholar
Stewart, DW, Ragg, PG, Sheppard, S, Chalkiadis, GA: The severity and duration of postoperative pain and analgesia requirements in children after tonsillectomy, orchidopexy, or inguinal hernia repair. Pediatr.Anesth. 2012; 22 (2): 136–43.Google Scholar
Anderson, BJ, Woollard, GA, Holford, NH: Acetaminophen analgesia in children: placebo effect and pain resolution after tonsillectomy. Eur.J.Clin.Pharmacol. 2001; 57 (8): 559–69.Google Scholar
Anderson, BJ, Holford, NH, Woollard, GA, Kanagasundaram, S, Mahadevan, M: Perioperative pharmacodynamics of acetaminophen analgesia in children. Anesthesiology. 1999; 90 (2): 411–21.Google Scholar
Anderson, B, Cranswick, N: The placebo (I shall please)–is it so pleasing in children? Paediatr.Anaesth. 2005; 15 (10): 809–13.Google Scholar
Simmons, K, Ortiz, R, Kossowsky, J, Krummenacher, P, Grillon, C, Pine, D, et al: Pain and placebo in pediatrics: a comprehensive review of laboratory and clinical findings. J.Pain. 2014; 155 (11): 2229–35.Google Scholar
Weimer, K, Gulewitsch, MD, Schlarb, AA, Schwille-Kiuntke, J, Klosterhalfen, S, Enck, P: Placebo effects in children: a review. Pediatr.Res. 2013; 74 (1): 96–102.Google Scholar
Krummenacher, P, Kossowsky, J, Schwarz, C, Brugger, P, Kelley, JM, Meyer, A, et al: Expectancy-induced placebo analgesia in children and the role of magical thinking. J.Pain. 2014; 15 (12): 1282–93.Google Scholar
Bjornsson, MA, Simonsson, US: Modelling of pain intensity and informative dropout in a dental pain model after naproxcinod, naproxen and placebo administration. Br.J.Clin.Pharmacol. 2011; 71 (6): 899–906.Google Scholar
Benedetti, F: Placebo and endogenous mechanisms of analgesia. Handb.Exp.Pharmacol. 2007; 177: 393–413.Google Scholar
Marchand, S, Gaumond, I: Placebo and nocebo: how to enhance therapies and avoid unintended sabotage to pain treatment. Pain.Manag. 2013; 3 (4): 285–94.Google Scholar
Zaccara, G, Giovannelli, F, Schmidt, D: Placebo and nocebo responses in drug trials of epilepsy. Epilepsy. Behav. 2015; 43: 128–34.Google Scholar
Manchikanti, L, Pampati, V, Damron, K: The role of placebo and nocebo effects of perioperative administration of sedatives and opioids in interventional pain management. Pain.Physician. 2005; 8 (4): 349–55.Google ScholarPubMed
Rothman, KJ, Michels, KB: The continuing unethical use of placebo controls. N.Engl.J.Med. 1994; 331 (6): 394–8.Google Scholar
Sheiner, LB: A new approach to the analysis of analgesic drug trials, illustrated with bromfenac data. Clin.Pharmacol.Ther. 1994; 56 (3): 309–22.Google Scholar
Anderson, BJ, Hannam, JA: Considerations when using pharmacokinetic/pharmacodynamic modeling to determine the effectiveness of simple analgesics in children. Expert.Opin. Drug.Metab.Toxicol. 2015; 11 (9): 1393–408.CrossRefGoogle ScholarPubMed
Hannam, J, Anderson, BJ: Explaining the acetaminophen-ibuprofen analgesic interaction using a response surface model. Paediatr.Anaesth. 2011; 21 (12): 1234–40.Google Scholar
Gal, P, Gilman, JT: Drug disposition in neonates with patent ductus arteriosus. Ann.Pharmacother. 1993; 27 (11): 1383–8.Google Scholar
Rabbitts, JA, Groenewald, CB, Rasanen, J: Geographic differences in perioperative opioid administration in children. Pediatr.Anesth. 2012; 22 (7): 676–81.Google Scholar
Klockars, JG, Hiller, A, Munte, S, van Gils, MJ, Taivainen, T: Spectral entropy as a measure of hypnosis and hypnotic drug effect of total intravenous anesthesia in children during slow induction and maintenance. Anesthesiology. 2012; 116 (2): 340–51.Google Scholar
Henthorn, TK, Liu, Y, Mahapatro, M, Ng, KY: Active transport of fentanyl by the blood-brain barrier. J.Pharmacol.Exp.Ther. 1999; 289 (2): 1084–9.Google Scholar
Hamabe, W, Maeda, T, Kiguchi, N, Yamamoto, C, Tokuyama, S, Kishioka, S: Negative relationship between morphine analgesia and P-glycoprotein expression levels in the brain. J.Pharmacol.Sci. 2007; 105 (4): 353–60.Google Scholar
Wietasch, JK, Scholz, M, Zinserling, J, Kiefer, N, Frenkel, C, Knufermann, P, et al: The performance of a target-controlled infusion of propofol in combination with remifentanil: a clinical investigation with two propofol formulations. Anesth.Analg. 2006; 102 (2): 430–7.Google Scholar
Choi, L, Ferrell, BA, Vasilevskis, EE, Pandharipande, PP, Heltsley, R, Ely, EW, et al: Population pharmacokinetics of fentanyl in the critically ill. Crit.Care.Med. 2016; 44 (1): 64–72.Google Scholar
Potts, AL, Cheeseman, JF, Warman, GR: Circadian rhythms and their development in children: implications for pharmacokinetics and pharmacodynamics in anesthesia. Pediatr.Anesth. 2011; 21 (3): 238–46.Google Scholar
Brainard, J, Gobel, M, Bartels, K, Scott, B, Koeppen, M, Eckle, T: Circadian rhythms in anesthesia and critical care medicine: potential importance of circadian disruptions. Semin.Cardiothorac.Vasc.Anesth. 2015; 19 (1): 49–60.Google Scholar
Reinberg, A, Reinberg, MA: Circadian changes of the duration of action of local anaesthetic agents. Naunyn-Schmiedebergs Arch.Pharmacol. 1977; 297 (2): 149–52.Google Scholar
Lemmer, B, Wiemers, R: Circadian changes in stimulus threshold and in the effect of a local anaesthetic drug in human teeth: studies with an electronic pulptester. Chronobiol.Intern. 1989; 6 (2): 157–62.Google Scholar
Debon, R, Chassard, D, Duflo, F, Boselli, E, Bryssine, B, Allaouchiche, B: Chronobiology of epidural ropivacaine: variations in the duration of action related to the hour of administration. Anesthesiology. 2002; 96 (3): 542–5.Google Scholar
Cheeseman, JF, Merry, AF, Pawley, MD, de Souza, RL, Warman, GR: The effect of time of day on the duration of neuromuscular blockade elicited by rocuronium. Anaesthesia. 2007; 62 (11): 1114–20.Google Scholar
Levi, FA, Zidani, R, Vannetzel, JM, Perpoint, B, Focan, C, Faggiuolo, R, et al: Chronomodulated versus fixed-infusion-rate delivery of ambulatory chemotherapy with oxaliplatin, fluorouracil, and folinic acid (leucovorin) in patients with colorectal cancer metastases: a randomized multi-institutional trial. J.Natl.Canc.Inst. 1994; 86 (21): 1608–17.Google Scholar
Kamali, F, Fry, JR, Bell, GD: Temporal variations in paracetamol absorption and metabolism in man. Xenobiotica. 1987; 17 (5): 635–41.Google Scholar
Halsas, M, Hietala, J, Veski, P, Jurjenson, H, Marvola, M: Morning versus evening dosing of ibuprofen using conventional and time-controlled release formulations. Int.J.Pharmaceut. 1999; 189 (2): 179–85.Google Scholar
Clench, J, Reinberg, A, Dziewanowska, Z, Ghata, J, Smolensky, M: Circadian changes in the bioavailability and effects of indomethacin in healthy subjects. Eur.J.Clin.Pharmacol. 1981; 20 (5): 359–69.Google Scholar
Mustofa, M, Suryawati, S, Dwiprahasto, I, Santoso, B: The relative bioavailability of diclofenac with respect to time of administration. Brit.J.Clin.Pharmacol. 1991; 32 (2): 246–7.Google Scholar
Ollagnier, M, Decousus, H, Cherrah, Y, Levi, F, Mechkouri, M, Queneau, P, et al: Circadian changes in the pharmacokinetics of oral ketoprofen. Clin.Pharmacokinet. 1987; 12 (5): 367–78.Google Scholar
Han, PY, Duffull, SB, Kirkpatrick, CM, Green, B: Dosing in obesity: a simple solution to a big problem. Clin.Pharmacol.Ther. 2007; 82 (5): 505–8.Google Scholar
Abernethy, DR, Greenblatt, DJ: Drug disposition in obese humans. An update. Clin.Pharmacokinet. 1986; 11 (3): 199–213.Google Scholar
Mulla, H, Johnson, TN. Dosing dilemmas in obese children. Arch.Dis.Child.Educ.Pract.Ed. 2010; 95 (4): 112–17.Google Scholar
Anderson, BJ, Holford, NH: Getting the dose right for obese children. Arch.Dis.Child. 2017; 102 (1): 54–5.Google Scholar
Anderson, BJ, Holford, NH: What is the best size predictor for dose in the obese child? Pediatr.Anesth. 2017; 27 (12): 1176–84.Google Scholar
Chidambaran, V, Venkatasubramanian, R, Sadhasivam, S, Esslinger, H, Cox, S, Diepstraten, J, et al: Population pharmacokinetic-pharmacodynamic modeling and dosing simulation of propofol maintenance anesthesia in severely obese adolescents. Pediatr.Anesth. 2015; 25 (9): 911–23.Google Scholar
Cortinez, LI, Anderson, BJ, Penna, A, Olivares, L, Munoz, HR, Holford, NH, et al: Influence of obesity on propofol pharmacokinetics: derivation of a pharmacokinetic model. Brit.J.Anaesth. 2010; 105 (4): 448–56.Google Scholar
Diepstraten, J, Chidambaran, V, Sadhasivam, S, Esslinger, HR, Cox, SL, Inge, TH, et al: Propofol clearance in morbidly obese children and adolescents: influence of age and body size. Clin.Pharmacokinet. 2012; 51 (8): 543–51.Google Scholar
Holford, NHG, Anderson, BJ: Allometric size: the scientific theory and extension to normal fat mass. Eur.J.Pharm.Sci. 2017; 109S: S59–S64.Google Scholar
Allegaert, K, Olkkola, KT, Owens, KH, Van de Velde, M, de Maat, MM, Anderson, BJ: Covariates of intravenous paracetamol pharmacokinetics in adults. BMC Anesthesiol. 2014; 14: 77.Google Scholar
Tham, LS, Wang, LZ, Soo, RA, Lee, HS, Lee, SC, Goh, BC, et al: Does saturable formation of gemcitabine triphosphate occur in patients? Canc.Chemother.Pharmacol. 2008; 63 (1): 55–64.Google Scholar
McCune, JS, Bemer, MJ, Barrett, JS, Scott Baker, K, Gamis, AS, Holford, NHG: Busulfan in infant to adult hematopoietic cell transplant recipients: a population pharmacokinetic model for initial and bayesian dose personalization. Clin.Canc.Res. 2014; 20 (3): 754–63.Google Scholar
Cortinez, LI, Anderson, BJ, Holford, NH, Puga, V, de la Fuente, N, Auad, H, et al: Dexmedetomidine pharmacokinetics in the obese. Eur.J.Clin.Pharmacol. 2015; 71 (12): 1501–8.Google Scholar
Van Boxtel, C, Holford, N, Danhof, M: In Vivo Study of Drug Action. Amsterdam: Elsevier, 1992.Google Scholar
Schnider, TW, Minto, CF, Shafer, SL, Gambus, PL, Andresen, C, Goodale, DB, et al: The influence of age on propofol pharmacodynamics. Anesthesiology. 1999; 90 (6): 1502–16.Google Scholar
Lerman, J. Pharmacology of inhalational anaesthetics in infants and children. Paediatr.Anaesth. 1992; 2: 191–203.Google Scholar
LeDez, KM, Lerman, J. The minimum alveolar concentration (MAC) of isoflurane in preterm neonates. Anesthesiology. 1987; 67 (3): 301–7.Google Scholar
Warner, MA, Kunkel, SE, Offord, KO, Atchison, SR, Dawson, B: The effects of age, epinephrine, and operative site on duration of caudal analgesia in pediatric patients. Anesth.Analg. 1987; 66 (10): 995–8.Google Scholar
Lerman, J, Robinson, S, Willis, MM, Gregory, GA: Anesthetic requirements for halothane in young children 0–1 month and 1–6 months of age. Anesthesiology. 1983; 59 (5): 421–4.Google Scholar
Molin, JC, Bendhack, LM: Clonidine induces rat aorta relaxation by nitric oxide-dependent and -independent mechanisms. Vascul.Pharmacol. 2004; 42 (1): 1–6.Google Scholar
Chugani, DC, Muzik, O, Juhasz, C, Janisse, JJ, Ager, J, Chugani, HT: Postnatal maturation of human GABAA receptors measured with positron emission tomography. Ann.Neurol. 2001; 49 (5): 618–26.Google Scholar
Herlenius, E, Lagercrantz, H: Development of neurotransmitter systems during critical periods. Exp.Neurol. 2004; 190 Suppl 1: S8–21.Google Scholar
Chugani, HT, Kumar, A, Muzik, O: GABA(A) receptor imaging with positron emission tomography in the human newborn: a unique binding pattern. Pediatr.Neurol. 2013; 48 (6): 459–62.Google Scholar
Koch, SC, Fitzgerald, M, Hathway, GJ: Midazolam potentiates nociceptive behavior, sensitizes cutaneous reflexes, and is devoid of sedative action in neonatal rats. Anesthesiology. 2008; 108 (1): 122–9.Google Scholar
Choudhuri, S, Klaassen, CD: Structure, function, expression, genomic organization, and single nucleotide polymorphisms of human ABCB1 (MDR1), ABCC (MRP), and ABCG2 (BCRP) efflux transporters. Int.J.Toxicol. 2006; 25 (4): 231–59.Google Scholar
Herd, DW, Anderson, BJ, Keene, NA, Holford, NH: Investigating the pharmacodynamics of ketamine in children. Paediatr.Anaesth. 2008; 18 (1): 36–42.Google Scholar
Dilger, JP: From individual to population: the minimum alveolar concentration curve. Curr.Opin.Anaesthesiol. 2006; 19 (4): 390–6.Google Scholar
de Jong, RH, Eger, EI: 2nd. MAC expanded: AD50 and AD95 values of common inhalation anesthetics in man. Anesthesiology. 1975; 42 (4): 384–9.Google Scholar
Gourlay, GK, Kowalski, SR, Plummer, JL, Cousins, MJ, Armstrong, PJ: Fentanyl blood concentration-analgesic response relationship in the treatment of postoperative pain. Anesth.Analg. 1988; 67 (4): 329–37.Google Scholar
Dutta, S, Matsumoto, Y, Ebling, WF: Is it possible to estimate the parameters of the sigmoid Emax model with truncated data typical of clinical studies? J.Pharm.Sci. 1996; 85 (2): 232–9.Google Scholar
Dixon, WJ: Staircase bioassay: the up-and-down method. Neurosci.Biobehav.Rev. 1991; 15 (1): 47–50.Google Scholar
Gorges, M, Zhou, G, Brant, R, Ansermino, JM: Sequential allocation trial design in anesthesia: an introduction to methods, modeling, and clinical applications. Paediatr.Anaesth. 2017; 27 (3): 240–7.Google Scholar
Hansen, MS, Mathiesen, O, Trautner, S, Dahl, JB: Intranasal fentanyl in the treatment of acute pain – a systematic review. Acta.Anaesthesiol.Scand. 2012; 56 (4): 407–19.Google Scholar
Lotsch, J, Skarke, C, Liefhold, J, Geisslinger, G: Genetic predictors of the clinical response to opioid analgesics: clinical utility and future perspectives. Clin.Pharmacokinet. 2004; 43 (14): 983–1013.Google Scholar
Hannam, J, Anderson, BJ, Veyckemans, F: Tears at breakfast. Pediatr.Anesth. 2012; 22 (4): 419.Google Scholar
Jimenez, N, Anderson, GD, Shen, DD, Nielsen, SS, Farin, FM, Seidel, K, et al: Is ethnicity associated with morphine’s side effects in children? Morphine pharmacokinetics, analgesic response, and side effects in children having tonsillectomy. Pediatr.Anesth. 2012; 22 (7): 669–75.Google Scholar
Myles, PS, Buchanan, FF, Bain, CR: The effect of hair colour on anaesthetic requirements and recovery time after surgery. Anaesth. Intensive Care. 2012; 40 (4): 683–9.Google Scholar
Kaitin, KI: Deconstructing the drug development process: the new face of innovation. Clin.Pharmacol.Ther. 2010; 87 (3): 356–61.Google Scholar
Long, LS, Ved, S, Koh, JL: Intraoperative opioid dosing in children with and without cerebral palsy. Paediatr.Anaesth. 2009; 19 (5): 513–20.Google Scholar
Valkenburg, AJ, de Leeuw, TG, Tibboel, D, Weber, F: Lower bispectral index values in children who are intellectually disabled. Anesth.Analg. 2009; 109 (5): 1428–33.Google Scholar
Hallett, BR, Chalkiadis, GA: Suspected opioid-induced hyperalgesia in an infant. Br.J.Anaesth. 2012; 108 (1): 116–18.Google Scholar
Meibohm, B, Beierle, I, Derendorf, H: How important are gender differences in pharmacokinetics? Clin.Pharmacol. 2002; 41 (5): 329–42.Google Scholar
Beierle, I, Meibohm, B, Derendorf, H: Gender differences in pharmacokinetics and pharmacodynamics. Int.J.Clin.Pharm.Ther. 1999; 37 (11): 529–47.Google Scholar
Apfelbaum, JL, Grasela, TH, Hug, CC, Jr., McLeskey, CH, Nahrwold, ML, Roizen, MF, et al: The initial clinical experience of 1819 physicians in maintaining anesthesia with propofol: characteristics associated with prolonged time to awakening. Anesth.Analg. 1993; 77 (4 Suppl): S10–14.Google Scholar
Hoymork, SC, Raeder, J, Grimsmo, B, Steen, PA: Bispectral index, predicted and measured drug levels of target-controlled infusions of remifentanil and propofol during laparoscopic cholecystectomy and emergence. Acta Anaesth. Scand. 2000; 44 (9): 1138–44.Google Scholar
Hoymork, SC, Raeder, J, Grimsmo, B, Steen, PA: Bispectral index, serum drug concentrations and emergence associated with individually adjusted target-controlled infusions of remifentanil and propofol for laparoscopic surgery. Br.J.Anaesth. 2003; 91 (6): 773–80.Google Scholar
Vuyk, J, Oostwouder, CJ, Vletter, AA, Burm, AG, Bovill, JG: Gender differences in the pharmacokinetics of propofol in elderly patients during and after continuous infusion. Br.J.Anaesth. 2001; 86 (2): 183–8.Google Scholar
Hoymork, SC, Raeder, J. Why do women wake up faster than men from propofol anaesthesia? Br.J.Anaesth. 2005; 95 (5): 627–33.Google Scholar
Niesters, M, Dahan, A, Kest, B, Zacny, J, Stijnen, T, Aarts, L, et al: Do sex differences exist in opioid analgesia? A systematic review and meta-analysis of human experimental and clinical studies. J.Pain. 2010; 151 (1): 61–8.Google Scholar
Sarton, E, Olofsen, E, Romberg, R, den Hartigh, J, Kest, B, Nieuwenhuijs, D, et al: Sex differences in morphine analgesia: an experimental study in healthy volunteers. Anesthesiology. 2000; 93 (5): 1245–54; discussion 6A.Google Scholar
Dahan, A, Kest, B, Waxman, AR, Sarton, E: Sex-specific responses to opiates: animal and human studies. Anesth.Analg. 2008; 107 (1): 83–95.Google Scholar
Rabbitts, JA, Groenewald, CB, Dietz, NM, Morales, C, Rasanen, J: Perioperative opioid requirements are decreased in hypoxic children living at altitude. Pediatr.Anesth. 2010; 20 (12): 1078–83.Google Scholar
Sadhasivam, S, Chidambaran, V, Ngamprasertwong, P, Esslinger, HR, Prows, C, Zhang, X, et al: Race and unequal burden of perioperative pain and opioid related adverse effects in children. Pediatrics. 2012; 129 (5): 832–8.Google Scholar
Sadhasivam, S, Krekels, EH, Chidambaran, V, Esslinger, HR, Ngamprasertwong, P, Zhang, K, et al: Morphine clearance in children: does race or genetics matter? J. Opioid Manag. 2012; 8 (4): 217–26.Google Scholar
Chidambaran, V, Ngamprasertwong, P, Vinks, AA, Sadhasivam, S: Pharmacogenetics and anesthetic drugs. Curr.Clin.Pharmacol. 2012; 7 (2): 78–101.Google Scholar
Cohen, M, Sadhasivam, S, Vinks, AA: Pharmacogenetics in perioperative medicine. Curr.Opin.Anaesthesiol. 2012; 25 (4): 419–27.Google Scholar
Stamer, UM, Stuber, F: Pharmacogenetics of anesthetic and analgesic agents: CYP2D6 genetic variations. Anesthesiology. 2005; 103 (5): 1099; author reply 101.Google Scholar
Williams, DG, Patel, A, Howard, RF: Pharmacogenetics of codeine metabolism in an urban population of children and its implications for analgesic reliability. Brit.J.Anaesth. 2002; 89 (6): 839–45.Google Scholar
Rigby-Jones, A, Sneyd, JR: Cardiovascular changes after achieving constant effect site concentration of propofol. Anaesthesia. 2008; 63 (7): 780.Google Scholar
Hutchinson, MR, Coats, BD, Lewis, SS, Zhang, Y, Sprunger, DB, Rezvani, N, et al: Proinflammatory cytokines oppose opioid-induced acute and chronic analgesia. Brain.Behav.Immun. 2008; 22 (8): 1178–89.Google Scholar
Candiotti, KA, Yang, Z, Morris, R, Yang, J, Crescimone, NA, Sanchez, GC, et al: Polymorphism in the interleukin-1 receptor antagonist gene is associated with serum interleukin-1 receptor antagonist concentrations and postoperative opioid consumption. Anesthesiology. 2011; 114 (5): 1162–8.Google Scholar
Lotsch, J, Geisslinger, G: Relevance of frequent mu-opioid receptor polymorphisms for opioid activity in healthy volunteers. J. Pharmacogenomics. 2006; 6 (3): 200–10.Google Scholar
Walter, C, Lotsch, J: Meta-analysis of the relevance of the OPRM1 118A> G genetic variant for pain treatment. J.Pain. 2009; 146 (3): 270–5.Google Scholar
Ross JR, Rutter D, Welsh K, Joel SP, Goller K, Wells AU, et al: Clinical response to morphine in cancer patients and genetic variation in candidate genes. J. Pharmacogenomics. 2005; 5 (5): 324–36.Google Scholar
Liem, EB, Joiner, TV, Tsueda, K, Sessler, DI: Increased sensitivity to thermal pain and reduced subcutaneous lidocaine efficacy in redheads. Anesthesiology. 2005; 102 (3): 509–14.Google Scholar
Lotsch, J, Geisslinger, G: Pharmacogenetics of new analgesics. Br.J.Pharmacol. 2011; 163 (3): 447–60.Google Scholar
Tournier, N, Decleves, X, Saubamea, B, Scherrmann, JM, Cisternino, S: Opioid transport by ATP-binding cassette transporters at the blood-brain barrier: implications for neuropsychopharmacology. Curr.Pharm.Des. 2011; 17 (26): 2829–42.Google Scholar
Holford, NH, Buclin, T: Safe and effective variability-a criterion for dose individualization. Ther. Drug Monit. 2012; 34 (5): 565–8.Google Scholar
Palomaki, GE, Bradley, LA, Douglas, MP, Kolor, K, Dotson, WD: Can UGT1A1 genotyping reduce morbidity and mortality in patients with metastatic colorectal cancer treated with irinotecan? An evidence-based review. Genet.Med. 2009; 11 (1): 21–34.Google Scholar
Fredriksson, A, Archer, T, Alm, H, Gordh, T, Eriksson, P: Neurofunctional deficits and potentiated apoptosis by neonatal NMDA antagonist administration. Behav. Brain Res. 2004; 153 (2): 367–76.Google Scholar
Wang, C, Sadovova, N, Fu, X, Schmued, L, Scallet, A, Hanig, J, et al: The role of the N-methyl-D-aspartate receptor in ketamine-induced apoptosis in rat forebrain culture. Neuroscience. 2005; 132 (4): 967–77.Google Scholar
Bates, E, Reilly, J, Wulfeck, B, Dronkers, N, Opie, M, Fenson, J, et al: Differential effects of unilateral lesions on language production in children and adults. Brain. Lang. 2001; 79 (2): 223–65.Google Scholar
Ansermino, M, Basu, R, Vandebeek, C, Montgomery, C: Nonopioid additives to local anaesthetics for caudal blockade in children: a systematic review. Paediatr.Anaesth. 2003; 13 (7): 561–73.Google Scholar
Dodwell, ER, Latorre, JG, Parisini, E, Zwettler, E, Chandra, D, Mulpuri, K, et al: NSAID exposure and risk of nonunion: a meta-analysis of case-control and cohort studies. Calcif.Tissue.Int. 2010; 87 (3): 193–202.Google Scholar
Anderson, BJ, Ralph, CJ, Stewart, AW, Barber, C, Holford, NH: The dose-effect relationship for morphine and vomiting after day-stay tonsillectomy in children. Anaesth.Intens.Care. 2000; 28 (2): 155–60.Google Scholar
Weinstein, MS, Nicolson, SC, Schreiner, MS: A single dose of morphine sulfate increases the incidence of vomiting after outpatient inguinal surgery in children. Anesthesiology. 1994; 81 (3): 572–7.Google Scholar
Bouillon, T, Bruhn, J, Radu-Radulescu, L, Andresen, C, Cohane, C, Shafer, SL: A model of the ventilatory depressant potency of remifentanil in the non-steady state. Anesthesiology. 2003; 99 (4): 779–87.Google Scholar
Standing, JF, Hammer, GB, Sam, WJ, Drover, DR. Pharmacokinetic-pharmacodynamic modeling of the hypotensive effect of remifentanil in infants undergoing cranioplasty. Paediatr.Anaesth. 2010; 20 (1): 7–18.Google Scholar
References
Win, NN, Fukayama, H, Kohase, H, Umino, M: The different effects of intravenous propofol and midazolam sedation on hemodynamic and heart rate variability. Anaesth.Analges. 2005; 101: 97–102.Google Scholar
Rantanen, M: Novel multiparameter approach for measurement of nociception at skin incision during general anaesthesia. Br.J.Anaesth. 2006; 96: 367–76.Google Scholar
Jensen, EW, Valencia, JF, López, A, Anglada, T, Agustí, M, Ramos, Y, Serra, R, Jospin, M, Pineda, P, Gambus, P: Monitoring hypnotic effect and nociception with two EEG-derived indices, qCON and qNOX, during general anaesthesia. Acta Anaesthesiol.Scand. 2014; 58: 933–41.Google Scholar
Viertiö-Oja, H, Maja, V, Särkelä, M, Talja, P, Tenkanen, N, Tolvanen-Laakso, H, Paloheimo, M, Vakkuri, A, Yli-Hankala, A, Meriläinen, P: Description of the Entropy algorithm as applied in the Datex-Ohmeda S/5 Entropy Module. Acta.Anaesthesiol.Scand. 2004; 48: 154–61.Google Scholar
Bouillon, TW: Pharmacodynamic interaction between propofol and remifentanil regarding hypnosis, tolerance of laryngoscopy, bispectral index, and electroencephalographic approximate entropy. Anesthesiology. 2004; 100: 1353–72.Google Scholar
Jensen, EW, Lindholm, P, Henneberg, S: Auto regressive modeling with exogenous input of auditory evoked potentials to produce an on-line depth of anaesthesia index. Methods.Inf.Med. 1996; 35: 256–260.Google Scholar
Walling, PT, Kenneth, NH: Nonlinear changes in brain dynamics during emergence from sevoflurane anaesthesia: preliminary exploration using new software. Anesthesiology 2006; 105: 927–35.Google Scholar
Lalitha, V, Eswaran, C: Automated detection of anesthetic depth levels using chaotic features with artificial neural networks. J.Med.Syst. 2007; 31: 445–52.Google Scholar
Natarajan, K, Acharya, R, Alias, F, Tiboleng, T, Puthusserypady, SK: Nonlinear analysis of EEG signals at different mental states. Biomed.Eng.OnLine. 2004; 3: 7–18.Google Scholar
Ferenets, R, Lipping, T, Anier, A, Jantti, V, Melto, S, Hovilehto, S: Comparison of entropy and complexity measures for the assessment of depth of sedation. IEEE Trans.Biomed.Eng. 2006; 53: 1067–77.Google Scholar
Hornero, R, Abásolo, D, Escudero, J, Gómez, C: Nonlinear analysis of electroencephalogram and magnetoencephalogram recordings in patients with Alzheimer’s disease. Philos.Trans.Royal.Soc. A. 2009; 367: 317–36.Google Scholar
Struys, MM, Jensen, EW, Smith, W, Smith, NT, Rampil, I, Dumortier, FJ, Mestach, C, Mortier, EP. Performance of the ARX-derived auditory evoked potential index as an indicator of anesthetic depth: a comparison with bispectral index and hemodynamic measures during propofol administration. Anesthesiology. 2002; 96: 803–16.Google Scholar
Leslie, K, Sessler, DI, Smith, WD, Larson, MD, Ozaki, M, Blanchard, D, Crankshaw, DP: Prediction of movement during propofol/nitrous oxide anaesthesia: performance of concentration, electroencephalographic, pupillary, and hemodynamic indicators. Anesthesiology. 1996; 84: 52–63.Google Scholar
Kato, M, Komatsu, T, Kimura, T, Sugiyama, F, Nakashima, K, Shimada, Y: Spectral analysis of heart rate variability during isoflurane anaesthesia. Anesthesiology. 1992; 77: 669–74.Google Scholar
Sato, A, Sato, Y, Shimada, F, Torigata, Y: Varying changes in heart rate produced by nociceptive stimulation of the skin in rats at different temperatures. Brain.Res. 1976; 110: 301–11.Google Scholar
Jeanne, M, Logier, R, De Jonckheere, J, Tavernier, B: Heart rate variability during total intravenous anaesthesia: effects of nociception and analgesia. Auton.Neurosci. 2009; 147: 91–6.Google Scholar
Jeanne, M, Clément, C, De Jonckheere, J, Logier, R, Tavernier, B: Variations of the analgesia nociception index during general anaesthesia for laparoscopic abdominal surgery. J.Clin.Monit.Comput. 2012; 26: 289–94.Google Scholar
Smith, WD, Dutton, RC, Smith, NT: Measuring the performance of anesthetic depth indicators. Anesthesiology. 1996; 84: 38–51.Google Scholar
Gugino, LD, Chabot, RJ, Prichep, LS, John, ER, Formanek, V: Quantitative EEG changes associated with loss and return of consciousness in healthy adult volunteers anaesthetized with propofol or sevoflurane. Brit.J.Anaesth. 2001; 87: 421–8.Google Scholar
Feshchenko, VA, Veselis, RA, Reinsel, RA: Propofol-induced alpha rhythm. Neuropsychobiology. 2004; 50: 257–66.Google Scholar
Hindriks, R, van Putten, MJ: Meanfield modeling of propofol-induced changes in spontaneous EEG rhythms. Neuroimage. 2002; 60: 2323–34.Google Scholar
Ching, S, Cimenser, A, Purdon, PL, Brown, EN, Kopell, NJ: Thalamocortical model for a propofol-induced alpha-rhythm associated with loss of consciousness. Proc.Natl.Acad.Sci.USA. 2010; 107: 22665–70.Google Scholar
Melia, U, Vallverdú, M, Borrat, X, Valencia, JF, Jospin, M, Jensen, EW, Gambus, P, Caminal, P: Prediction of nociceptive responses during sedation by linear and non-linear measures of EEG signals in high frequencies. PloS.One. 2015; 10: e0123464.Google Scholar
Valencia, JF, Melia, U, Vallverdú, M, Borrat, X, Jospin, M, Jensen, EW, Gambus, P, Caminal, P. Assessment of nociceptive responsiveness levels during sedation-analgesia by entropy analysis of EEG. Entropy. 2016; 18: 103–14.Google Scholar
Guyon, I: An introduction to variable and feature selection. J.Mach.Learn.Res. 2003; 3: 1157–82.Google Scholar
References
Kuck, K, Johnson, KB: The three laws of autonomous and closed-loop systems in anesthesia. Anesth.Analg. 2017; 124 (2): 377–80.Google Scholar
Brogi, E, Cyr, S, Kazan, R, Giunta, F, Hemmerling, TM: Clinical performance and safety of closed-loop systems: a systematic review and meta-analysis of randomized controlled trials. Anesth.Analg. 2016; 124 (2): 446–55.Google Scholar
Glass, PS: Anesthetic drug interactions: an insight into general anesthesia – its mechanism and dosing strategies. Anesthesiology. 1998; 88 (1): 5–6.Google Scholar
Rampil, IJ, King, BS: Volatile anesthetics depress spinal motor neurons. Anesthesiology. 1996; 85 (1): 129–34.Google Scholar
Sonner, JM, Antognini, JF, Dutton, RC, Flood, P, Gray, AT, Harris, RA, et al: Inhaled anesthetics and immobility: mechanisms, mysteries, and minimum alveolar anesthetic concentration. Anesth.Analg. 2003; 97 (3): 718–40.Google Scholar
Vuyk, J, Engbers, FH, Burm, AGL, Vletter, AA, Griever, GE, Olofsen, E, et al: Pharmacodynamic interaction between propofol and alfentanil when given for induction of anesthesia. Anesthesiology. 1996; 84 (2): 288–99.Google Scholar
Hendrickx, JFA, Eger, EI, Sonner, JM, Shafer, SL: Is synergy the rule? A review of anesthetic interactions producing hypnosis and immobility. Anesth.Analg. 2008; 107 (2): 494–506.Google Scholar
Krüger-Thiemer, E: Continuous intravenous infusion and multicompartment accumulation. Eur.J.Pharmacol. 1968; 4 (3): 317–24.Google Scholar
Hughes, MA, Glass, PS, Jacobs, JR: Context-sensitive half-time in multicompartment pharmacokinetic models for intravenous anesthetic drugs. Anesthesiology. 1992; 76 (3): 334–41.Google Scholar
Bailey, JM: Context-sensitive half-times and other decrement times of inhaled anesthetics. Anesth.Analg. 1997; 85 (3): 681–6.Google Scholar
Youngs, EJ, Shafer, SL: Pharmacokinetic parameters relevant to recovery from opioids. Anesthesiology. 1994; 81 (4): 833–42.Google Scholar
Eger, EI, Shafer, SL: Tutorial: context-sensitive decrement times for inhaled anesthetics. Anesth.Analg. 2005; 101 (3): 688–96.Google Scholar
Frei, FJ, Zbinden, AM, Thomson, DA, Rieder, HU: Is the end-tidal partial pressure of isoflurane a good predictor of its arterial partial pressure? Br.J.Anaesth. 1991; 66 (3): 331–9.Google Scholar
Kennedy, RR, Minto, C, Seethepalli, A: Effect-site half-time for burst suppression is longer than for hypnosis during anaesthesia with sevoflurane. Br.J.Anaesth. 2008; 100 (1): 72–7.Google Scholar
Lerou, JGC, Mourisse, J: Applying a physiological model to quantify the delay between changes in end-expired concentrations of sevoflurane and bispectral index. Br.J.Anaesth. 2007; 99 (2): 226–36.Google Scholar
Absalom, AR, Mani, V, De Smet, T, Struys, MM: Pharmacokinetic models for propofol – defining and illuminating the devil in the detail. Br.J.Anaesth. 2009; 103 (1): 26–37.Google Scholar
Schnider, TW, Minto, CF, Gambus, PL, Andresen, C, Goodale, DB, Shafer, SL, et al: The influence of method of administration and covariates on the pharmacokinetics of propofol in adult volunteers. Anesthesiology. 1998; 88 (5): 1170–82.Google Scholar
Quasha, AL, Eger, EI, Tinker, JH: Determination and applications of MAC. Anesthesiology. 1980; 53 (4): 315–34.Google Scholar
Gaumann, DM, Mustaki, JP, Tassonyi, E: MAC-awake of isoflurane, enflurane and halothane evaluated by slow and fast alveolar washout. Br.J.Anaesth. 1992; 68 (1): 81–4.Google Scholar
Kimura, T, Watanabe, S, Asakura, N, Inomata, S, Okada, M, Taguchi, M: Determination of end-tidal sevoflurane concentration for tracheal intubation and minimum alveolar anesthetic concentration in adults. Anesth.Analg. 1994; 79 (2): 378–81.Google Scholar
Kennedy, RR: Effect-site estimation of volatile anaesthetic agents: Beyond MAC fractions as a target for anaesthesia delivery. Trends in Anaesthesia and Critical Care 2013; 3 (4): 211–15.Google Scholar
Roberts, FL, Dixon, J, Lewis, GT, Tackley, RM, Prys-Roberts, C: Induction and maintenance of propofol anaesthesia. A manual infusion scheme. Anaesthesia. 1988; 43 Suppl: 14–17.Google Scholar
Cowles, AL, Borgstedt, HH, Gillies, AJ: Digital computer prediction of the optimal anaesthetic inspired concentration. Br.J.Anaesth. 1972; 44: 420–5.Google Scholar
Mapleson, WW: The theoretical ideal fresh-gas flow sequence at the start of low-flow anaesthesia. Anaesthesia. 1998; 53 (3): 264–72.Google Scholar
Lowe, HJ, Ernst, EA: The Qualitative Practice of Anaesthesia: Use of Closed Circuit. Baltimore/London: Williams & Wilkins, 1981.Google Scholar
da Silva, JM, Mapleson, WW, Vickers, MD: Quantitative study of Lowe’s square-root-of-time method of closed-system anaesthesia. Br.J.Anaesth. 1997; 79 (1): 103–12.Google Scholar
Bangaari, A, Panda, NB, Puri, GD: A simple method for evaluation of the uptake of isoflurane and its comparison with the square root of time model. Indian.J.Anaesth. 2013; 57 (3): 230–5.Google Scholar
Hendrickx, JF, Vandeput, DM, De Geyndt, AM, De Ridder, KP, Haenen, JS, Deloof, T, et al: Maintaining sevoflurane anesthesia during low-flow anesthesia using a single vaporizer setting change after overpressure induction. J.Clin.Anesth. 2000; 12 (4): 303–7.Google Scholar
Hendrickx, JFA, Dewulf, BBC, De Mey, N, Carette, R, Deloof, T, De Cooman, S, et al: Development and performance of a two-step desflurane-O(2)/N(2)O fresh gas flow sequence. J.Clin.Anesth. 2008; 20 (7): 501–7.Google Scholar
Van Zundert, T, Brebels, A, Hendrickx, J, Carette, R, De Cooman, S, Gatt, S, et al: Derivation and prospective testing of a two-step sevoflurane-O2-N2O low fresh gas flow sequence. Anaesth.Intens.Care. 2009; 37 (6): 911–17.Google Scholar
Albert, V, Mndolo, S, Harrison, EM, O’Sullivan, E, Wilson, IH, Walker, IA: Lifebox pulse oximeter implementation in Malawi: evaluation of educational outcomes and impact on oxygen desaturation episodes during anaesthesia. Anaesthesia. 2017; 72 (6): 686–93.Google Scholar
Sykes, MK: Continuous monitoring of alveolar and inspiratory concentrations of anesthetic and respiratory gases is difficult and potentially unsafe. J.Clin.Monit. 1987; 3 (2): 116–22.Google Scholar
Fahy, BG, Chau, DF: The technology of processed electroencephalogram monitoring devices for assessment of depth of anesthesia. Anesth.Analg. 2017 3. doi:10.1213/ANE.0000000000002331. [Epub ahead of print]Google Scholar
Absalom, AR, De Keyser, R, Struys, MMRF: Closed loop anesthesia: are we getting close to finding the holy grail? Anesth.Analg. 2011; 112 (3): 516–18.Google Scholar
Upton, HD, Ludbrook, GL, Wing, A, Sleigh, JW: Intraoperative analgesia nociception index guided fentanyl administration during sevoflurane anesthesia in lumbar discectomy and laminectomy. Anesth.Analg. 2017; 125 (1): 81–90.Google Scholar
Hannivoort, LN, Vereecke, HEM, Proost, JH, Heyse, BEK, Eleveld, DJ, Bouillon, TW, et al: Probability to tolerate laryngoscopy and noxious stimulation response index as general indicators of the anaesthetic potency of sevoflurane, propofol, and remifentanil. Br.J.Anaesth. 2016; 116 (5): 624–31.Google Scholar
Struys, MMRF, De Smet, T, Glen, JIB, Vereecke, HEM, Absalom, AR, Schnider, TW: The history of target-controlled infusion. Anesth.Analg. 2016; 122 (1): 56–69.Google Scholar
Glen, JB: The development of “Diprifusor”: a TCI system for propofol. Anaesthesia. 1998; 53 Suppl 1: 13–21.Google Scholar
Absalom, AR, Glen, JIB, Zwart, GJC, Schnider, TW, Struys, MMRF: Target-controlled infusion. Anesth.Analg. 2016; 122 (1): 70–8.Google Scholar
Varvel, J, Donoho, D, Shafer, S: Measuring the predictive performance of computer-controlled infusion pumps. J.Pharmacokinet.Biopharm. 1992; 20 (1): 63–94.Google Scholar
Schnider, TW, Minto, CF, Struys, MMRF, Absalom, AR: The safety of target-controlled infusions. Anesth.Analg. 2016; 122 (1): 79–85.Google Scholar
Ross, JA, Wloch, RT, White, DC, Hawes, DW: Servo-controlled closed-circuit anaesthesia. A method for the automatic control of anaesthesia produced by a volatile agent in oxygen. Br.J.Anaesth. 1983; 55 (11): 1053–60.Google Scholar
O’Callaghan, AC, Hawes, DW, Ross, JA, White, DC, Wloch, RT: Uptake of isoflurane during clinical anaesthesia. Servo-control of liquid anaesthetic injection into a closed-circuit breathing system. Br.J.Anaesth. 1983; 55 (11): 1061–4.Google Scholar
Westenskow, DR, Zbinden, AM, Thomson, DA, Kohler, B: Control of end-tidal halothane concentration. Part A: anaesthesia breathing system and feedback control of gas delivery. Br.J.Anaesth. 1986; 58 (5): 555–62.Google Scholar
Zbinden, AM, Frei, F, Westenskow, DR, Thomson, DA: Control of end-tidal halothane concentration. Part B: verification in dogs. Br.J.Anaesth. 1986; 58 (5): 563–71.Google Scholar
Lortat-Jacob, B, Billard, V, Buschke, W, Servin, F: Assessing the clinical or pharmaco-economical benefit of target controlled desflurane delivery in surgical patients using the Zeus® anaesthesia machine. Anaesthesia. 2009; 64 (11): 1229–35.Google Scholar
Tay, S, Weinberg, L, Peyton, P, Story, D, Briedis, J: Financial and environmental costs of manual versus automated control of end-tidal gas concentrations. Anaesth.Intens.Care. 2013; 41 (1): 95–101.Google Scholar
Lucangelo, U, Garufi, G, Marras, E, Ferluga, M, Turchet, F, Bernabè, F, et al: End-tidal versus manually-controlled low-flow anaesthesia. J.Clin.Monit.Comput. 2014; 28 (2): 117–21.Google Scholar
Ryan, SM, Nielsen, CJ: Global warming potential of inhaled anesthetics: application to clinical use. Anesth.Analg. 2010; 111 (1): 92–8.Google Scholar
Sulbaek, Andersen MP, Sander, SP, Nielsen, OJ, Wagner, DS, Sanford, TJ, Wallington, TJ: Inhalation anaesthetics and climate change. Br.J.Anaesth. 2010; 105 (6): 760–6.Google Scholar
Kennedy, RR: New technology in anaesthesia: friend or foe? J.Clin.Monit.Comput. 2014; 28 (2): 113–16.Google Scholar
Carette, R, De Wolf, AM, Hendrickx, JFA: Automated gas control with the Maquet FLOW-i. J.Clin.Monit.Comput. 2016; 30 (3): 341–6.Google Scholar
Sieber, TJ, Frei, CW, Derighetti, M, Feigenwinter, P, Leibundgut, D, Zbinden, AM: Model-based automatic feedback control versus human control of end-tidal isoflurane concentration using low-flow anaesthesia. Br.J.Anaesth. 2000; 85 (6): 818–25.Google Scholar
Dussaussoy, C, Peres, M, Jaoul, V, Liu, N, Chazot, T, Picquet, J, et al: Automated titration of propofol and remifentanil decreases the anesthesiologist’s workload during vascular or thoracic surgery: a randomized prospective study. J.Clin.Monit.Comput. 2014; 28 (1): 35–40.Google Scholar
Franci, P, Bertamini, A, Bertamini, O, Pilla, T, Busetto, R: Clinical evaluation of an end-tidal target-controlled infusion closed-loop system for isoflurane administration in horses undergoing surgical procedures. Vet.J. 2012; 192 (2): 206–11.Google Scholar
Kennedy, RR, McKellow, MA, French, RA: The effect of predictive display on the control of step changes in effect site sevoflurane levels. Anaesthesia. 2010; 65 (8): 826–30.Google Scholar
Kennedy, RR, French, RA: The development of a system to guide volatile anaesthetic administration. Anaesth.Intens.Care. 2011; 39 (2): 182–90.Google Scholar
Katoh, T, Uchiyama, T, Ikeda, K: Effect of fentanyl on awakening concentration of sevoflurane. Br.J.Anaesth. 1994; 73 (3): 322–5.Google Scholar
Katoh, T, Suguro, Y, Kimura, T, Ikeda, K: Morphine does not affect the awakening concentration of sevoflurane. Can.J.Anaesth. 1993; 40 (9): 825–8.Google Scholar
Struys, MMRF, Sahinovic, M, Lichtenbelt, BJ, Vereecke, HEM, Absalom, AR: Optimizing intravenous drug administration by applying pharmacokinetic/pharmacodynamic concepts. Br.J.Anaesth. 2011; 107 (1): 38–47.Google Scholar
Kennedy, RR: Seeing the future of anesthesia drug dosing: moving the art of anesthesia from impressionism to realism. Anesth.Analg. 2010; 111 (2): 252–5.Google Scholar
van den Berg, JP, Vereecke, HEM, Proost, JH, Eleveld, DJ, Wietasch, JKG, Absalom, AR, et al: Pharmacokinetic and pharmacodynamic interactions in anaesthesia. A review of current knowledge and how it can be used to optimize anaesthetic drug administration. Br.J.Anaesth. 2017; 118 (1): 44–57.Google Scholar
DeCou, J, Johnson, K: An introduction to predictive modelling of drug concentration in anaesthesia monitors. Anaesthesia. 2017; 2;72: 58–69.Google Scholar
Coppens, M, Van Limmen, JGM, Schnider, T, Wyler, B, Bonte, S, Dewaele, F, et al: Study of the time course of the clinical effect of propofol compared with the time course of the predicted effect-site concentration: Performance of three pharmacokinetic-dynamic models. Br.J.Anaesth. 2010; 104 (4): 452–8.Google Scholar
Cirillo, V, Zito Marinosci, G, De Robertis, E, Iacono, C, Romano, GM, Desantis, O, et al: Navigator® and SmartPilot® View are helpful in guiding anesthesia and reducing anesthetic drug dosing. Minerva.Anestesiol. 2015 19; 81 (11): 1163–9.Google Scholar
Short, TG, Hannam, JA, Laurent, S, Campbell, D, Misur, M, Merry, AF, et al: Refining target-controlled infusion. Anesth.Analg. 2016; 122 (1): 90–7.Google Scholar
O’Hara, DA, Bogen, DK, Noordergraaf, A: The use of computers for controlling the delivery of anesthesia. Anesthesiology. 1992; 77 (3): 563–81.Google Scholar
Mayo, CW, Bickford, RG, Faulconer, A: Electroencephalographically controlled anesthesia in abdominal surgery. J.Am.Med.Assoc. 1950 25; 144 (13): 1081–3.Google Scholar
Hull, CJ, Van Beem, HB, McLeod, K, Sibbald, A, Watson, MJ: A pharmacodynamic model for pancuronium. Br.J.Anaesth. 1978; 50 (11): 1113–23.Google Scholar
Stanski, DR, Ham, J, Miller, RD, Sheiner, LB: Pharmacokinetics and pharmacodynamics of d-tubocurarine during nitrous oxide-narcotic and halothane anesthesia in man. Anesthesiology. 1979; 51 (3): 235–41.Google Scholar
Cass, NM, Lampard, DG, Brown, WA, Coles, JR: Computer controlled muscle relaxation: a comparison of four muscle relaxants in the sheep. Anaesth.Intens.Care. 1976; 4 (1): 16–22.Google Scholar
Lampard, DG, Brown, WA, Cass, NM, Ng, KC: Computer-controlled muscle paralysis with atracurium in the sheep. Anaesth.Intens.Care. 1986 Feb; 14 (1): 7–11.Google Scholar
Murchie, CJ, Kenny, GN: Comparison among manual, computer-assisted, and closed-loop control of blood pressure after cardiac surgery. J.Cardiothorac.Anesth. 1989; 3 (1): 16–19.Google Scholar
Monk, CR, Millard, RK, Hutton, P, Prys-Roberts, C: Automatic arterial pressure regulation using isoflurane: comparison with manual control. Br.J.Anaesth. 1989; 63 (1): 22–30.Google Scholar
Schwilden, H, Schuttler, J, Stoeckel, H: Closed-loop feedback control of methohexital anesthesia by quantitative EEG analysis in humans. Anesthesiology. 1987; 67 (3): 341–7.Google Scholar
Schwilden, H, Stoeckel, H, Schuttler, J. Closed-loop feedback control of propofol anaesthesia by quantitative EEG analysis in humans. Br.J.Anaesth. 1989; 62 (3): 290–6.Google Scholar
Mortier, E, Struys, M, De Smet, T, Versichelen, L, Rolly, G: Closed-loop controlled administration of propofol using bispectral analysis. Anaesthesia. 1998; 53 (8): 749–54.Google Scholar
Kenny, GN, Mantzaridis, H: Closed-loop control of propofol anaesthesia. Br.J.Anaesth. 1999; 83 (2): 223–8.Google Scholar
Morley, A, Derrick, J, Mainland, P, Lee, BB, Short, TG: Closed loop control of anaesthesia: an assessment of the bispectral index as the target of control. Anaesthesia. 2000; 55 (10): 953–9.Google Scholar
Struys, MM, De Smet, T, Versichelen, LF, Van De Velde, S, Van den Broecke, R, Mortier, EP: Comparison of closed-loop controlled administration of propofol using bispectral index as the controlled variable versus “standard practice” controlled administration. Anesthesiology. 2001; 95 (1): 6–17.Google Scholar
Struys, MMRF, De Smet, T, Greenwald, S, Absalom, AR, Bingé, S, Mortier, EP: Performance evaluation of two published closed-loop control systems using bispectral index monitoring: a simulation study. Anesthesiology. 2004; 100 (3): 640–7.Google Scholar
Locher, S, Stadler, KS, Boehlen, T, Bouillon, T, Leibundgut, D, Schumacher, PM, et al: A new closed-loop control system for isoflurane using bispectral index outperforms manual control. Anesthesiology. 2004; 101 (3): 591–602.Google Scholar
Luginbühl, M, Bieniok, C, Leibundgut, D, Wymann, R, Gentilini, A, Schnider, TW: Closed-loop control of mean arterial blood pressure during surgery with alfentanil: clinical evaluation of a novel model-based predictive controller. Anesthesiology. 2006; 105 (3): 462–70.Google Scholar
West, N, Dumont, GA, van Heusden, K, Petersen, CL, Khosravi, S, Soltesz, K, et al: Robust closed-loop control of induction and maintenance of propofol anesthesia in children. Paediatr.Anaesth. 2013; 23 (8): 712–19.Google Scholar
Liu, N, Chazot, T, Hamada, S, Landais, A, Boichut, N, Dussaussoy, C, et al: Closed-loop coadministration of propofol and remifentanil guided by bispectral index: a randomized multicenter study. Anesth.Analg. 2011; 112 (3): 546–57.Google Scholar
Puri, GD, Mathew, PJ, Biswas, I, Dutta, A, Sood, J, Gombar, S, et al: A multicenter evaluation of a closed-loop anesthesia delivery system: a randomized controlled trial. Anesth.Analg. 2016; 122 (1): 106–14.Google Scholar
Hemmerling, TM, Arbeid, E, Wehbe, M, Cyr, S, Taddei, R, Zaouter, C: Evaluation of a novel closed-loop total intravenous anaesthesia drug delivery system: a randomized controlled trial. BJA. 2013; 110 (6): 1031–9.Google Scholar
Wehbe, M, Arbeid, E, Cyr, S, Mathieu, PA, Taddei, R, Morse, J, et al: A technical description of a novel pharmacological anesthesia robot. J.Clin.Monit.Comput. 2014; 28 (1): 27–34.Google Scholar
Pasin, L, Nardelli, P, Pintaudi, M, Greco, M, Zambon, M, Cabrini, L, et al: Closed-loop delivery systems versus manually controlled administration of total IV anesthesia. Anesth.Analg. 2017; 124 (2): 456–64.Google Scholar
Zaouter, C, Hemmerling, TM, Lanchon, R, Valoti, E, Remy, A, Leuillet, S, et al: The feasibility of a completely automated total IV anesthesia drug delivery system for cardiac surgery. Anesth.Analg. 2016; 123 (4): 885–93.Google Scholar
Biswas, I, Mathew, PJ, Singh, RS, Puri, GD: Evaluation of closed-loop anesthesia delivery for propofol anesthesia in pediatric cardiac surgery. Paediatr.Anaesth. 2013; 23 (12): 1145–52.Google Scholar
Zaouter, C, Hemmerling, TM, Mion, S, Leroux, L, Remy, A, Ouattara, A: Feasibility of automated propofol sedation for transcatheter aortic valve implantation: a pilot study. Anesth.Analg. 2017 Nov; 125 (5): 1505–12Google Scholar
Kennedy, RR: Lessons from drug interaction displays. In Absalom AR & Mason KP (eds), Total Intravenous Anesthesia and Target Controlled Infusions. Springer 2017.Google Scholar